Filing Details
- Accession Number:
- 0000885590-17-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-16 17:04:34
- Reporting Period:
- 2017-03-14
- Filing Date:
- 2017-03-16
- Accepted Time:
- 2017-03-16 17:04:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Valeant Pharmaceuticals International Inc. | VRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1374175 | Paul Herendeen | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Acquisiton | 2017-03-14 | 24,000 | $10.72 | 174,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents volume-weighted average price of purchases of 24,000 shares of common stock (Shares) of Valeant Pharmaceuticals International, Inc. (the Company) at prices ranging from $10.60 to $10.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of Shares purchased by the reporting person at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
